DCVC Opportunity Fund II GP, LLC
CIK 0001668343
Annualised vol
39.414836%
Beta
0.409451
HHI
7353.016607
Top-10 weight
100.0%
VaR 95%
3.793236%
VaR 99%
8.080868%
Max drawdown
67.780648%
Matched value
100.0%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| RXRX | UNCHANGED | Recursion Pharmaceuticals, Inc. | CL A | 75629V104 | 14,500,687 | 84.3 | 3951141.0 |
| IONQ | REDUCED | IonQ, Inc. | CL A | 46222L108 | 2,700,548 | 15.7 | 50705.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | 17,201,235 | 2 | 39.414836 | 0.409451 | 67.780648 |
| 2026-03-31 | 2026-05-15 | 13,866,319 | 2 | 39.921283 | 0.408218 | 71.119911 |
| 2025-12-31 | 2026-02-17 | 16,587,374 | 2 | 41.943458 | 0.404359 | 79.834137 |
| 2025-09-30 | 2025-11-14 | 19,281,568 | 1 | 42.567005 | 0.40336 | 81.701032 |
| 2025-03-31 | 2025-05-15 | 81,483,428 | 2 | 10.918978 | 0.103467 | 25.878218 |
| 2024-12-31 | 2025-02-14 | 113,008,415 | 2 | 10.060777 | 0.095335 | 23.852121 |